Cambridge, MA, United States of America

Harald Jüppner

This inventor holds 3 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harald Jüppner. Retrieved from https://idiyas.com/inventor/harald-janduumlppner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 61(Granted Patents)


Location History:

  • Boston, MA (US) (2002)
  • Cambridge, MA (US) (2002 - 2003)

Company Filing History:


Years Active: 2002-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Harald Jüppner

Introduction

Harald Jüppner is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of molecular biology. With a total of 3 patents, Jüppner has made remarkable advancements in understanding parathyroid hormone receptors and their implications in medical treatments.

Latest Patents

One of Jüppner's latest patents involves the discovery of nucleic acid encoding the PTH1R receptor. This invention relates to novel parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) receptors isolated from zebrafish. The receptors share homology with previously identified PTH/PTHrP receptors. The patent provides isolated nucleic acid molecules encoding the zebrafish PTH1R and PTH3R receptors, along with receptor polypeptides, vectors, host cells, and recombinant methods for their production. Additionally, it includes screening methods for identifying agonists and antagonists of PTH1R and PTH3R receptor activity, as well as diagnostic and therapeutic methods.

Another significant patent by Jüppner focuses on bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP). This patent discloses novel biologically active peptides and pharmaceutical compositions containing these peptides. It also outlines synthetic and recombinant methods for producing the peptides and methods for treating conditions characterized by decreases in bone mass using therapeutically effective pharmaceutical compositions. Furthermore, it includes methods for screening candidate compounds for their effects on parathyroid hormone receptor action.

Career Highlights

Jüppner's career is marked by his dedication to advancing medical science through innovative research. His work has significantly impacted the understanding of bone metabolism and related disorders. He is affiliated with The General Hospital Corporation, where he continues to contribute to groundbreaking research.

Collaborations

Throughout his career, Jüppner has collaborated with esteemed colleagues, including Thomas J Gardella and Henry M Kronenberg. These collaborations have further enriched his research and expanded the scope of his inventions.

Conclusion

Harald Jüppner's innovative work in the field of parathyroid hormone research has led to significant advancements in medical science. His patents not only enhance the understanding of hormone receptors but also pave

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…